Nothing said here yet.
to join the conversation.
| Martha GeoffreyChairman and CEO | Sell | 50,000 | $4.8M | Thu, Oct 15 |
| Marinaro MichaelEVP, Pres MedSurg and Americas | Sell | 10,420 | $1.0M | Thu, Oct 15 |
| KIIL HARRY SKIPEVP & President Cardiovascular | Sell | 1,483 | $138.9K | Wed, Sep 16 |
| Kevin Hern | Sell | $32.5K | Mon, Aug 24 | Thu, Aug 27 |
| Richard Dean Dr McCormick | Sell | $8.0K | Thu, Jul 30 | Thu, Aug 13 |
| Thomas H Tuberville | Sell | $32.5K | Mon, Aug 26 | Wed, Aug 5 |
| Alan Armstrong | Buy | $8.0K | Fri, Mar 27 | Tue, Jul 21 |
| Gilbert Cisneros | Sell | $8.0K | Fri, May 15 | Fri, Jun 5 |
| Julie Johnson | Sell | $8.0K | Wed, May 7 | Tue, Jun 3 |
Medtronic (NYSE:MDT) reported positive real-world outcomes for its Affera Mapping and Ablation System in atrial fibrillation and ventricular tachycardia patients.
Medtronic grew revenue by 14% in the first quarter of its fiscal 2027.
The latest trading day saw Medtronic (MDT) settling at $97.11, representing a +2.46% change from its previous close.
For questions about this article or underlying research, email [email protected].
For questions about this article or underlying research, email [email protected].
Up to 100 scholarships will be awarded globally to students pursuing degrees or credentials in health tech fields.NORTHAMPTON, MA / ACCESS Newswire / October 28, 2026 / , a global leader in healthcare technology, announced applications are open for the second…
Medtronic will release its second-quarter earnings soon, and analysts anticipate a low single-digit profit dip.
Medtronic's 49-year dividend streak sounds impressive until you meet the two medical device rivals that have been raising payouts even longer, and the differences in yield, valuation, and balance sheet strength could reshape how you think about income…
Medtronic just extended a nearly half-century dividend streak, but its raise barely outpaces inflation while rivals like Abbott and J&J grow payouts far faster.
Medtronic (NYSE:MDT) reported positive real world registry results for its Sphere-9 catheter and PulseSelect PFA System at APHRS 2026.
Medtronic has delivered a solid 51.6% share price gain over the past three years, while rolling out new cardiac devices and digital tools that could reshape how it earns and collects cash.